We’re expanding our Strategic Advisory Board with two former FDA leaders, Tala Fakhouri and Sean Khozin. Their guidance ensures Weave stays grounded in how regulators actually assess a submission, not in assumptions about it.
Press release
Two Former FDA Leaders Join Weave Bio’s Strategic Advisory Board
Related news
Press release
Weave Bio Announces Collaboration with Takeda to Deploy AI-Native Regulatory Automation Across Key Drug Development Activities
Press release
Weave Bio Enables Global Submissions
News
The Regulatory Expert Is Not Obsolete: Redefining Human Expertise in an AI-Accelerated Submission Environment
Press release